FDA Investigator David R Delucia

David R Delucia has conducted inspections on 141 sites in 1 countries as of 08 Jul 2022. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
141
Last Inspection Date:
08 Jul 2022
Investigator Role:
FDA Investigator
Redica ID:
100007898
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with David R Delucia:
Alejandra Mcclellan, Alice S Tsao, Althea A Williams, Amatul H Marium, Amber D Brodas, Amy Kim, Amy Wyan Mai, Andrew F Cohen, Andrew J Molesky, Ann B Okon, Ann M Stewart, Anne E Carpenter, Anthony M Criscuolo, Jr, Anthony R Rauert, Antoinette O Smallhorne, Arduino Frankovic, Ashley Polizzotto, Ayorinde O Babalola, Aziz A Mamur, Benjamin Bustamante, Benton M Ketron, Bijoy Panicker, Brandy N Lepage, Brian M Brodman, Brittney Hu, Catherine M Beer, Charanjeet Jassal, Charisse K Green, Christian Parra, Christine M Rivera, Coleburn E Vielehr, Cosmon L Barrett, David A Carlson, David H Smith, Demitria J Xiradakis, Devina K Budhan, Devon O Seymour, Diane B Radice, Diane C Thibodeau, Dipesh K Shah, Donald G Gordon, Dongping Dai, PhD, Dr. Robert C Horan, MD, Edouard Viard, Edwin A Evangelista, Elizabeth H Slazak, Emilio Z Azukwu, Erin L Nagel, Evan Tong, Evelyn Taha, Felix Maldonado, Frank Verni, Gabriel Feng, Gam S Zamil, Gary J Lehr, Gary T Greco, Gianine E Tompkins, Gregson A Joseph, Guerlain Ulysse, Harry J Brewer, Hien Albright, Iram R Hassan, PhD, Irina Gaberman, Jacqueline S Warner, James A Liubicich, James D Bridges, Jana J Lau, Jananiga Vanniyasingam, Jane C Chen, Jason Kwong, Jay T Wong, Jennifer J Edmiston, Jessica M Monteiro, Joel R Merriman, John A Podsadowski, Jose Ohernandez Guzman, Joseph Duca, Joseph H Procopio, Jr, Joseph Maselli, Joy P Matthias, Juan Rjimenez Garcia, Judy Keihl, Justin A Boyd, Karen F Tomaziefski, Karen L Kosar, Karishma G Gopaul, Kenneth H Williams, Kerry A Kurdilla, Kerry D Noto, Kevin A Gonzalez, Kim Lthomas Cruse, Kim M Downing, Kimberley A Ricketts, Kimberly A Coward, Kwong P Lee, Lauren E Blaser, Lawrence R Johnson, Lawrence W Farina, LCDR Chad N Thompson, Linda M Sacco, Lydia E Gonzalez, Marc S Neubauer, Margaret E Sarles, Marlene L Davis, Matthew A Spataro, Matthew D Schnittker, Meisha A Mandal, Melissa B Libby, Melka F Argaw, Meredith P Soehl, Investigator, Michael A Charles, Michael G Sinkevich, Michael Levin, Michael R Dominick, Michael S Chuley, Michael W Burd, Michele C Murray Schrade, Mindy M Chou, Morgan J Matthews, Mouhamed H Halwani, Nancy A Saxenian Emmons, Nazmul Hassan, Neil J Bonzagni, PhD MPH, Nerizza B Guerin, Nicholas C Mendiola, Nicholas E Stuhr, Nicholas J Morici, Nicole Vaught, Omadevi Somai, Investigator, Omolola A Shola Philips, Parul M Patel, Patrick C Klotzbuecher, Paul E Stein, Paul Mouris, Perry T Nichols, Peter Abel, Peter Caparelli, Peter M Trunk, Peter R Caparelli, Philip F Istafanos, DMV, MS, Phyllis J Wilson, Rachael A Moliver, Raihan A Chowdhury, Rajiv R Srivastava, Randolph Campos Santiago, Raymond Liu, Richard D Manney, Richard Ferfoglia, Rita F Monfort, Robert C Howard, Robert C Steyert, Robert E Moncayo, Rochelle K Kimmel, Ronald Ifraimov, Samina S Khan, Samuel A Francis, Samuel T Walker, Sarah A Meehan, Sarah K Graham, Satheesh Thomas, Schultz, Scott R Izyk, Seemay A Lee, Shari L Kahn, Sharon Ferraro, Simone E Pitts, Sony Mathews, Stephanie T Durso, Steven M Weinman, Sunita Vij, Susan M Joseph, Susan T Hadman, Susan W Ting, Syeda N Mahazabin, Taina Pierre Pierre, Tanvir Kaium, Tanya R Syffrard, Tara K Carmody, Tara K Normandin, Terry Bridgewater, Thomas Cote, Thomas J Mooney, Tracy M Portelli, Troy R Petrillo, Uduak M Inokon, Valerie C Reed, Vanessa M Williams, Vincent T Duncan, Wai H Lam, Wayne J Meyer, Weston K Szymanski, William K Dagley, William V Thompson, Willy A Orantes, Xiaoping Guan, Yasmin B Rios, Yuyan Liang

David R Delucia's Documents

Publish Date Document Type Title
January, 2000 EIR Contract Pharmacal Corp. - EIR, 2000-01-21
September, 2000 EIR Contract Pharmacal Corp. - EIR, 2000-09-01
January, 2001 EIR Contract Pharmacal Corp. - EIR, 2001-01-12
July, 2000 FDA 483 Response Jerome Stevens Pharmaceuticals, Inc. - Form 483R, 2000-09-21
September, 2000 FDA 483 Contract Pharmacal Corp. - Form 483, 2000-09-01
October, 2000 FDA 483 Pharma Tech Products, LLC - Form 483, 2000-10-27
January, 2001 FDA 483 Contract Pharmacal Corp. - Form 483, 2001-01-12
September, 2000 FDA 483 Response Contract Pharmacal Corp. - Form 483R, 2000-11-09
April, 2000 EIR Taro Pharmaceutical Laboratories, Inc. - EIR, 2000-04-05
April, 2000 FDA 483 Response Taro Pharmaceutical Laboratories, Inc. - Form 483R, 2000-08-16
November, 2000 FDA 483 Alden Optical - Form 483, 2000-11-03
July, 2001 FDA 483 C.R. Bard Inc. - Form 483, 2001-07-13
June, 2002 EIR Contract Pharmacal Corp. - EIR, 2002-06-20
November, 2001 EIR Kaufmans Bakery Inc - EIR, 2001-11-13
April, 2000 FDA 483 Taro Pharmaceutical Laboratories, Inc. - Form 483, 2000-04-05
July, 2000 EIR Jerome Stevens Pharmaceuticals, Inc. - EIR, 2000-07-26
May, 2000 FDA 483 Jerome Stevens Pharmaceuticals, Inc. - Form 483, 2000-05-04
October, 2000 FDA 483 Response Pharma Tech Products, LLC - Form 483R, 2000-12-08
January, 2000 FDA 483 Richmond Wholesale, Inc. - Form 483, 2000-01-07
July, 2000 FDA 483 Jerome Stevens Pharmaceuticals, Inc. - Form 483, 2000-07-26
March, 2001 FDA 483 Taro Pharmaceutical Laboratories, Inc. - Form 483, 2001-03-23
October, 2000 FDA 483 Taro Pharmaceutical Laboratories, Inc. - Form 483, 2000-10-12
July, 2001 EIR C.R. Bard Inc. - EIR, 2001-07-13
November, 2001 FDA 483 Kaufmans Bakery Inc - Form 483, 2001-11-13
May, 2000 EIR Jerome Stevens Pharmaceuticals, Inc. - EIR, 2000-05-04
July, 2000 EIR LNK International, Inc. - EIR, 2000-12-05

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more